Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of olanzapine and fluoxetine
combined on all the visits as compared with the baseline visit in patients with bipolar
disorder, measured by the total score of the Montgomery-Asberg Depression Rating Scale
(MADRS).